IBL Healthcare Ltd. announced Financial Results for the period ended June 30, 2017.
The company’s Revenue for the period increased by 3 percent in the outgoing year, whereas the Profit after Taxation for the Period increased by 11 percent.
The board has not recommended a Cash Dividend for the year ended June 30, 2017. The board issued no bonus or right shares.
Comparison of Key Financials
|
Unconsolidated Profit and Loss Account – For the Year Ended |
|||
|
Key Financials |
2017 |
2016 |
% Change |
|
Amounts in PKR ‘000 |
|||
|
Revenue |
1,189,799 |
1,156,421 |
2.89% |
|
Cost of Sales |
791,899 |
773,809 |
2.34% |
|
GP |
397,900 |
382,612 |
4.00% |
|
Dist: Cost |
147,752 |
136,726 |
8.06% |
|
Admin: Expenses |
45,621 |
39,268 |
16.18% |
|
Operating Profit |
253,970 |
223,059 |
13.86% |
|
Finance Cost |
1,403 |
2,464 |
-43.06% |
|
Profit before Taxation |
252,567 |
220,595 |
14.49% |
|
Taxation |
54,149 |
41,701 |
29.85% |
|
PAT |
198,418 |
178,894 |
10.91% |
|
EPS – Basic & diluted |
4.04 |
3.68 |
9.78% |
Company release on Earnings Report can be accessed here.
